Lars S. Maier

25.7k total citations · 1 hit paper
379 papers, 15.3k citations indexed

About

Lars S. Maier is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Lars S. Maier has authored 379 papers receiving a total of 15.3k indexed citations (citations by other indexed papers that have themselves been cited), including 291 papers in Cardiology and Cardiovascular Medicine, 156 papers in Molecular Biology and 64 papers in Surgery. Recurrent topics in Lars S. Maier's work include Cardiac electrophysiology and arrhythmias (150 papers), Ion channel regulation and function (108 papers) and Cardiovascular Function and Risk Factors (55 papers). Lars S. Maier is often cited by papers focused on Cardiac electrophysiology and arrhythmias (150 papers), Ion channel regulation and function (108 papers) and Cardiovascular Function and Risk Factors (55 papers). Lars S. Maier collaborates with scholars based in Germany, United States and United Kingdom. Lars S. Maier's co-authors include Donald M. Bers, Gerd Hasenfuß, Stefan Wagner, Burkert Pieske, Samuel Sossalla, Stefan Neef, Joan Heller Brown, Tong Zhang, Nataliya Dybkova and Luiz Belardinelli and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Lars S. Maier

359 papers receiving 15.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pluripotency of spermatogonial stem cells from adult mouse testis

2006 636 citations Lars S. Maier, Stefan Wagner et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lars S. Maier Germany	62	10.0k	8.8k	1.8k	1.7k	1.3k	379	15.3k
Minoru Horie Japan	66	11.9k 1.2×	8.6k 1.0×	1.8k 1.0×	1.7k 1.0×	1.9k 1.5×	553	18.3k
Steven R. Houser United States	69	7.6k 0.8×	8.8k 1.0×	2.5k 1.4×	1.8k 1.1×	987 0.8×	235	14.0k
Thomas Force United States	67	6.5k 0.7×	8.9k 1.0×	1.5k 0.8×	787 0.5×	1.1k 0.8×	158	16.8k
Luiz Belardinelli United States	76	14.1k 1.4×	8.5k 1.0×	1.4k 0.7×	2.3k 1.4×	1.3k 1.0×	400	20.4k
Peter H. Backx Canada	65	6.6k 0.7×	7.7k 0.9×	1.8k 1.0×	2.2k 1.3×	1.0k 0.8×	206	14.1k
Gordon F. Tomaselli United States	79	15.7k 1.6×	10.1k 1.1×	1.8k 1.0×	3.5k 2.1×	603 0.5×	327	21.8k
Gerald W. Dorn United States	78	7.0k 0.7×	13.8k 1.6×	1.4k 0.8×	1.7k 1.0×	1.9k 1.5×	184	19.3k
Erhe Gao United States	72	5.2k 0.5×	9.0k 1.0×	1.8k 1.0×	1.0k 0.6×	2.5k 2.0×	280	15.6k
Masashi Mukoyama Japan	56	8.0k 0.8×	4.5k 0.5×	1.7k 0.9×	889 0.5×	1.8k 1.4×	259	15.3k
John N. Lorenz United States	68	4.8k 0.5×	9.2k 1.0×	1.2k 0.6×	1.0k 0.6×	1.7k 1.3×	168	13.4k

Countries citing papers authored by Lars S. Maier

Since Specialization

Citations

This map shows the geographic impact of Lars S. Maier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars S. Maier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars S. Maier more than expected).

Fields of papers citing papers by Lars S. Maier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars S. Maier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars S. Maier. The network helps show where Lars S. Maier may publish in the future.

Co-authorship network of co-authors of Lars S. Maier

This figure shows the co-authorship network connecting the top 25 collaborators of Lars S. Maier. A scholar is included among the top collaborators of Lars S. Maier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars S. Maier. Lars S. Maier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mayer, M., et al.. (2025). MATLAB-based Methods Allow Precise, High-Throughput Quantification of Nuclear Morphology and Texture in Tachycardiomyopathy. Journal of Histochemistry & Cytochemistry. 73(3-4). 115–128. 2 indexed citations

Caravia, Xurde M., et al.. (2024). Gene editing in common cardiovascular diseases. Pharmacology & Therapeutics. 263. 108720–108720. 1 indexed citations

Büchner, Stefan, Henrik Fox, Olaf Oldenburg, et al.. (2024). Inflammation and Fibrosis in Sleep-Disordered Breathing after Acute Myocardial Infarction. Biomedicines. 12(1). 154–154. 1 indexed citations

Tafelmeier, Maria, Simon Lebek, Zdeněk Provazník, et al.. (2023). Sleep-disordered breathing is associated with fibrosis and impaired diastolic function. European Heart Journal. 44(Supplement_2).

Schach, Christian, et al.. (2023). Less major bleeding and higher hemoglobin after left atrial appendage closure in high‐risk patients: Data from a long‐term, longitudinal, two‐center observational study. Clinical Cardiology. 46(11). 1337–1344. 2 indexed citations

Ilić, Aleksandra, Lars S. Maier, Nduka C. Okwose, et al.. (2022). Gender Related Differences in the Clinical Presentation of Hypertrophic Cardiomyopathy—An Analysis from the SILICOFCM Database. Medicina. 58(2). 314–314. 16 indexed citations

Floerchinger, Bernhard, Zdeněk Provazník, Çhristof Schmid, et al.. (2022). SAR296968, a Novel Selective Na+/Ca2+ Exchanger Inhibitor, Improves Ca2+ Handling and Contractile Function in Human Atrial Cardiomyocytes. Biomedicines. 10(8). 1932–1932. 9 indexed citations

Renner, Kathrin, Alexander Nickel, Christoph Brochhausen, et al.. (2022). Tachycardiomyopathy entails a dysfunctional pattern of interrelated mitochondrial functions. Basic Research in Cardiology. 117(1). 45–45. 11 indexed citations

Žunkovič, Bojan, Marko Robnik‐Šikonja, Matjaž Kukar, et al.. (2022). Disease Progression of Hypertrophic Cardiomyopathy: Modeling Using Machine Learning. JMIR Medical Informatics. 10(2). e30483–e30483. 14 indexed citations

10.

Lebek, Simon, Florian Poschenrieder, Maria Tafelmeier, et al.. (2021). Abnormal P-Wave Terminal Force in Lead V1 is a Marker for Atrial Electrical Dysfunction but Not Structural Remodelling. ESC Heart Failure. 8(5). 4055–4066. 27 indexed citations

11.

Burel, Sophie, Kiersten M. Ruff, Rohit V. Pappu, et al.. (2020). Proteomic and functional mapping of cardiac NaV1.5 channel phosphorylation sites. The Journal of General Physiology. 153(2). 10 indexed citations

12.

Velicki, Lazar, Djordje G. Jakovljević, Aleksandra Ilić, et al.. (2020). Genetic determinants of clinical phenotype in hypertrophic cardiomyopathy. BMC Cardiovascular Disorders. 20(1). 516–516. 47 indexed citations

13.

Kreußer, Michael M., Lorenz Lehmann, Stanislav Keranov, et al.. (2014). Cardiac CaM Kinase II Genes δ and γ Contribute to Adverse Remodeling but Redundantly Inhibit Calcineurin-Induced Myocardial Hypertrophy. Circulation. 130(15). 1262–1273. 133 indexed citations

14.

Fischer, Thomas H., Nataliya Dybkova, Jonas Herting, et al.. (2014). Ca2+/Calmodulin-Dependent Protein Kinase II Equally Induces Sarcoplasmic Reticulum Ca2+ Leak in Human Ischaemic and Dilated Cardiomyopathy. European Journal of Heart Failure. 16(12). 1292–1300. 57 indexed citations

15.

Hamdani, Nazha, Judith Krysiak, Michael M. Kreußer, et al.. (2013). Crucial Role for Ca ²⁺ /Calmodulin-Dependent Protein Kinase-II in Regulating Diastolic Stress of Normal and Failing Hearts via Titin Phosphorylation. Circulation Research. 112(4). 664–674. 143 indexed citations

16.

Jacobshagen, Claudius, Nils Teucher, Albrecht Schmidt, et al.. (2008). Celecoxib Modulates Hypertrophic Signalling and Prevents Load-Induced Cardiac Dysfunction. European Journal of Heart Failure. 10(4). 334–342. 21 indexed citations

17.

Maier, Lars S. & Donald M. Bers. (2006). Review Focus on Calmodulin and Ca2+/Calmodulin Kinases in the Heart—Physiology and Pathophysiology. Cardiovascular Research. 70(3). iii–iii. 1 indexed citations

18.

Maier, Lars S. & Donald M. Bers. (2006). Announcement Review Focus on Calmodulin and Ca2+/Calmodulin Kinases in the Heart–Physiology and Pathophysiology. Cardiovascular Research. 71(2). ii–ii. 1 indexed citations

19.

Maier, Lars S. & Donald M. Bers. (2006). Review Focus on Calmodulin and Ca2+/Calmodulin Kinases in the Heart—Physiology and Pathophysiology. Cardiovascular Research. 70(1). v–v. 1 indexed citations

20.

Maier, Lars S. & Donald M. Bers. (2006). Review Focus on Calmodulin and Ca2+/Calmodulin Kinases in the Heart—Physiology and Pathophysiology. Cardiovascular Research. 71(1). vi–vi. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact